The new promising data presented by Martin Forster, M.D., Ph.D., at the ESMO Immuno-Oncology (IO) Annual Congress 2024 ...

as a treatment for patients with unresectable or metastatic NRAS-mutant melanoma who have progressed on or are intolerant to PD-1/PD-L1 based immune checkpoint inhibitors. IMM-1-104 is currently being ...

The following is a summary of “First-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients ...

The NHS has paid out tens of thousands to a man who developed an “uncontrollable” gambling problem after he was given a common Parkinson’s drug, The Independent can reveal Philip Stevens, a 66 year ...

By Dr. Chinta Sidharthan Sensor data from wearable devices analyzed over five years reveals walking and posture differences ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Robert J. White, 82, of Estero, Fla., and formerly Middlebury, Vt., passed away on Nov. 20, 2024, after a courageous 20-year battle with Parkinson’s disease. Born on April 4, 1942, in Rutland, Vt., to ...

Annovis Bio, Inc. operates in the biopharmaceutical industry, focusing on developing therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Their primary product, ...

Former Jets star Mark Gastineau confronted Packers legend Brett Favre last year, saying he hurt him by allowing the Giants' Michael Strahan to break his single-season sack record in 2001.

Komal Jhaveri, MD, FACP, breast oncologist and early drug development specialist at Memorial Sloan Kettering Cancer Center, ...

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

Dr. Gina Boerger, PT, DPT, of Fort Loramie, has authored a resource book for people with Parkinson’s disease. Dr. Boerger has ...